Drawing for ACCURASEE

USPTO serial 90843692

ACCURASEE

Reviewed by CopyMark Law Group

Reg. 7095938Status 700Registered
Filing date
Status date
Registration date
Jul 4, 2023
Examiner
TAYLOR, SLOAN H
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ACCURASEE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Thomas

301 FAYETTEVILLE STREET, SUITE 1400RALEIGH, NC 27601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Printed paper labels to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of bags sold filled with intravenous fluids used for the delivery of pharmaceutical preparations; printed paper labels to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of packaged pharmaceutical preparations in the nature of anticholinergics, anticholinesterases, anti-hypotensives, anesthetics, antibiotics, antiemetics, and sedatives; printed paper labels to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of packaged pharmaceutical preparations, intravenous bags filled with pharmaceuticals, syringes filled with pharmaceuticals, and vials filled with pharmaceuticals, with all of the aforementioned containing oncologic products and ancillary products, chemotherapy agents, anti-emitics, anti-infectives, anticholinergics, anticholinesterases, anti-hypotensives, biologicals, anesthetics for surgical and non-surgical use, antibiotics, and sedatives; printed paper labels to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of packaged biological preparations for the treatment of viral, infectious, metabolic, endocrine, musculoskeletal, joint, cardiovascular, cardiopulmonary, oncological, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders and cancerACTIVEFeb 21, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 4, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 4, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 24, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 23, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 23, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 2022DOCKASSIGNED TO EXAMINER—
Sep 23, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 26, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance